KARUNA REGMI: Open Payments
NPI 1831972751 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$612 in 36 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $96 · 2025 $612
Food & beverage: $612
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $174 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| Janssen Biotech, Inc. | 5 | $79 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Madrigal Pharmaceuticals | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| PFIZER INC. | 2 | $33 |
| Ardelyx, Inc. | 1 | $18 |
| ANI Pharmaceuticals, Inc. | 1 | $16 |
Products named: TREMFYA, MAVYRET, LINZESS, VOQUEZNA, REZDIFFRA, ENTYVIO, VELSIPITY, CREON.
Industry payments across NJ — which companies pay providers there.
